Insider · CIK 0001994972
Eric Adler
Files at LXEO (Lexeo Therapeutics, Inc.). First filing Feb 21, 2025, latest Nov 20, 2025.
Eric Adler files SEC Form 4 as officer at LXEO (Lexeo Therapeutics, Inc.). Since Feb 21, 2025, Eric Adler has reported 0 open-market buys worth $0 and 5 open-market sells worth $51k, the latest filed on Nov 20, 2025.
A track record needs three past buys with six months of prices behind them; Eric Adler has 0, so none is measured yet.
The newest scored trade: sold $5,701 of LXEO on Nov 18, 2025, filed Nov 20, 2025, scored 30 (weak). In the last 12 months: 0 buys worth $0 and 2 sells worth $36k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
LXEO: Lexeo Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Lexeo Therapeutics, Inc. | $5,701 615 shares | -1% | +413% from low-9% from high | |
| 35Weak | Lexeo Therapeutics, Inc. | $30k 3,382 shares | -4% | +435% from low-14% from high | |
| 30Weak | Lexeo Therapeutics, Inc. | $2,838 608 shares | -1% | +175% from low-56% from high | |
| 30Weak | Lexeo Therapeutics, Inc. | $1,623 585 shares | -1% | +81% from low-71% from high | |
| 15Weak | LXEOsell Lexeo Therapeutics, Inc. | $10k 2,359 shares | -3% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| May 18, 2026 | LXEO Lexeo Therapeutics, Inc. | 1,595 0.00% of outstanding | $8,074 | May 18, 2026 | $31k |
| Feb 18, 2026 | LXEO Lexeo Therapeutics, Inc. | 4,867 0.01% of outstanding | $31k | Feb 18, 2026 | $5,704 |
| Nov 18, 2025 | LXEO Lexeo Therapeutics, Inc. | 615 0.00% of outstanding | $5,704 | Nov 18, 2025 | $33k |
| Oct 17, 2025 | LXEO Lexeo Therapeutics, Inc. | 3,382 0.01% of outstanding | $30k | Oct 17, 2025 | $2,838 |
| Aug 18, 2025 | LXEO Lexeo Therapeutics, Inc. | 608 0.00% of outstanding | $2,838 | Aug 18, 2025 | none |
| May 16, 2025 | LXEO Lexeo Therapeutics, Inc. | 585 0.00% of outstanding | $1,623 | May 16, 2025 | $10k |
| Feb 19, 2025 | LXEO Lexeo Therapeutics, Inc. | 2,359 0.01% of outstanding | $10k | Feb 19, 2025 | none |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 18, 2025 | LXEO Lexeo Therapeutics, Inc. | SOpen-market sale Common Stock | -615 | $9.27 | $5,701 | 72,646 | Nov 20, 2025 |
| Oct 15, 2025 | LXEO Lexeo Therapeutics, Inc. | AGrant or award Common Stock | +9,570 | $0.00 | $0 | 76,643 | Oct 17, 2025 |
| Oct 17, 2025 | LXEO Lexeo Therapeutics, Inc. | SOpen-market sale Common Stock | -3,344 | $8.94 | $30k | 73,299 | Oct 17, 2025 |
| Oct 17, 2025 | LXEO Lexeo Therapeutics, Inc. | SOpen-market sale Common Stock | -38 | $9.56 | $363 | 73,261 | Oct 17, 2025 |
| Aug 18, 2025 | LXEO Lexeo Therapeutics, Inc. | SOpen-market sale Common Stock | -608 | $4.67 | $2,838 | 67,073 | Aug 20, 2025 |
| May 16, 2025 | LXEO Lexeo Therapeutics, Inc. | SOpen-market sale Common Stock | -585 | $2.77 | $1,623 | 67,681 | May 20, 2025 |
| Feb 19, 2025 | LXEO Lexeo Therapeutics, Inc. | SOpen-market sale Common Stock | -2,359 | $4.41 | $10k | 68,266 | Feb 21, 2025 |
| Jan 7, 2025 | LXEO Lexeo Therapeutics, Inc. | AGrant or award Common Stock | +43,750 | $0.00 | $0 | 70,625 | Jan 10, 2025 |
| Jan 7, 2025 | LXEO Lexeo Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +87,500 | $0.00 | $0 | 87,500 | Jan 10, 2025 |
Questions about Eric Adler
Answered from the filings on this page, as of the latest one.
Is Eric Adler buying or selling?
In the last 12 months Eric Adler reported 0 open-market buys worth $0 and 2 open-market sells worth $36k on SEC Form 4; the latest was sold $5,701 of LXEO on Nov 18, 2025. Grants, option exercises and tax withholding are not counted.
How did Eric Adler's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Eric Adler has 0.
Where does Eric Adler file Form 4?
Eric Adler has filed Form 4 at LXEO (Lexeo Therapeutics, Inc.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.